Role of lipoprotein-associated phospholipase A2 activity for the prediction of silent brain infarcts in women

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 811-815

  Riba Llena, Iolanda ^a   Penalba, Anna ^a   Pelegrí, Dolors ^b   Vilar, Andrea ^a   Jarca, Carme I ^c   Filomena, Josefina ^d   Montaner, Joan ^a,b   Delgado, Pilar ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Emergency Department   (Spain)

^d Institut Catala de Salut   (Spain)

Author keywords

Atherosclerosis; Brain infarction; Lipoprotein associated phospholipase A2; Platelet activating factor hydrolase; Stroke

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PROGNOSIS; SEX DIFFERENCE;

EID: 84911412861     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.11.003     Document Type: Article

References (32)

1. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol. 2007, 6:611-619.
2. Sacco R.L., Kasner S.E., Broderick J.P., Caplan L.R., Connors J.J., Culebras A., Elkind M.S., George M.G., Hamdan A.D., Higashida R.T., Hoh B.L., Janis L.S., Kase C.S., Kleindorfer D.O., Lee J.M., Moseley M.E., Peterson E.D., Turan T.N., Valderrama A.L., Vinters H.V. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44:2064-2089.
3. Dadu R.T., Fornage M., Virani S.S., Nambi V., Hoogeveen R.C., Boerwinkle E., Alonso A., Gottesman R.F., Mosley T.H., Ballantyne C.M. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke 2013, 44:1803-1808.
4. Hoshi T., Kitagawa K., Yamagami H., Furukado S., Hougaku H., Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005, 36:768-772.
5. van Dijk E.J., Prins N.D., Vermeer S.E., Vrooman H.A., Hofman A., Koudstaal P.J., Breteler M.M. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005, 112:900-905.
6. Schmidt R., Schmidt H., Pichler M., Enzinger C., Petrovic K., Niederkorn K., Horner S., Ropele S., Watzinger N., Schumacher M., Berghold A., Kostner G.M., Fazekas F. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006, 37:2910-2916.
7. Reitz C., Berger K., de Maat M.P., Stoll M., Friedrichs F., Kardys I., Witteman J.C., Breteler M.M. CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke 2007, 38:2356-2359.
8. Fornage M., Chiang Y.A., O'Meara E.S., Psaty B.M., Reiner A.P., Siscovick D.S., Tracy R.P., Longstreth W.T. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study. Stroke 2008, 39:1952-1959.
9. Wada M., Nagasawa H., Kurita K., Koyama S., Arawaka S., Kawanami T., Tajima K., Daimon M., Kato T. Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J.Neurol. Sci. 2008, 264:43-49.
10. Baune B.T., Ponath G., Rothermundt M., Roesler A., Berger K. Association between cytokines and cerebral MRI changes in the aging brain. J.Geriatr. Psychiatry Neurol. 2009, 22:23-34.
11. Yoshida M., Higashi K., Kobayashi E., Saeki N., Wakui K., Kusaka T., Takizawa H., Kashiwado K., Suzuki N., Fukuda K., Nakamura T., Watanabe S., Tada K., Machi Y., Mizoi M., Toida T., Kanzaki T., Tomitori H., Kashiwagi K., Igarashi K. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 2010, 211:475-479.
12. Jefferson A.L., Massaro J.M., Wolf P.A., Seshadri S., Au R., Vasan R.S., Larson M.G., Meigs J.B., Keaney J.F., Lipinska I., Kathiresan S., Benjamin E.J., DeCarli C. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 2007, 68:1032-1038.
13. Satizabal C.L., Zhu Y.C., Mazoyer B., Dufouil C., Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 2012, 78:720-727.
14. Wright C.B., Moon Y., Paik M.C., Brown T.R., Rabbani L., Yoshita M., DeCarli C., Sacco R., Elkind M.S. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009, 40:3466-3471.
15. 2 and risk of coronary disease, stroke and mortality: collaborative analysis of 32 prospective studies. Lancet 2010, 375:1536-1544. Lp-PLA(2) Studies Collaboration.
16. 2 activity and risk of recurrent stroke. Cerebrovasc. Dis. 2009, 27:42-50.
17. Delgado P., Chacón P., Penalba A., Pelegri D., García-Berrocoso T., Giralt D., Santamarina E., Ribó M., Maisterra O., Alvarez-Sabín J., Rosell A., Montaner J. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovasc. Dis. 2012, 33:150-158.
18. Massot A., Pelegri D., Penalba A., Arenillas J., Boada C., Giralt D., Ribó M., Molina C.A., Rosell A., Alvarez-Sabín J., Chacón P., Rovira A., Delgado P., Montaner J. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis 2011, 218:181-187.
19. Katan M., Moon Y.P., Paik M.C., Wolfert R.L., Sacco R.L., Elkind M.S. Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study. PLoS One 2014, 9:e83393.
20. De Jong F.J., Ikram M.K., Witteman J.C., Hofman A., de Jong P.T., Breteler M.M. Retinal vessel diameters and the role of inflammation in cerebrovascular disease. Ann. Neurol. 2007, 61:491-495.
21. Riba-Llena I., Jarca C.I., Mundet X., Tovar J.L., Orfila F., López-Rueda A., Nafría C., Fernández J.L., Castañé X., Domingo M., Alvarez-Sabín J., Fernández-Cortiñas I., Maisterra O., Montaner J., Delgado P. Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design. BMC Neurol. 2013, 13:130.
22. Delgado P., Riba-Llena I., Tovar J.L., Jarca C.I., Mundet X., López-Rueda A., Orfila F., Llussà J., Manresa J.M., Alvarez-Sabín J., Nafría C., Fernández J.L., Maisterra O., Montaner J. Prevalence and associated factors of silent brain infarcts in a Mediterranean cohort of hypertensives. Hypertension 2014, 64:658-663.
23. Marrugat J., Vila J., Baena-Díez J.M., Grau M., Sala J., Ramos R., Subirana I., Fitó M., Elosua R. Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study. Rev. Esp. Cardiol. 2011, 64:385-394.
24. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A.M., Kjeldsen S.E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R.E., Struijker Boudier H.A., Zanchetti A., Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Kjeldsen S.E., Erdine S., Narkiewicz K., Kiowski W., Agabiti-Rosei E., Ambrosioni E., Cifkova R., Dominiczak A., Fagard R., Heagerty A.M., Laurent S., Lindholm L.H., Mancia G., Manolis A., Nilsson P.M., Redon J., Schmieder R.E., Struijker-Boudier H.A., Viigimaa M., Filippatos G., Adamopoulos S., Agabiti-Rosei E., Ambrosioni E., Bertomeu V., Clement D., Erdine S., Farsang C., Gaita D., Kiowski W., Lip G., Mallion J.M., Manolis A.J., Nilsson P.M., O'Brien E., Ponikowski P., Redon J., Ruschitzka F., Tamargo J., van Zwieten P., Viigimaa M., Waeber B., Williams B., Zamorano J.L. The task force for the management of arterial hypertension of the European Society of Hypertension, the task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2007, 28:1462-1536.
25. Zhu Y.C., Dufouil C., Tzourio C., Chabriat H. Silent brain infarcts: a review of MRI diagnostic criteria. Stroke 2011, 42:1140-1145.
26. 2) activity. Clin. Chem. 2013, 59:A266.
27. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
28. Liu J., Wang W., Qi Y., Yong Q., Zhou G., Wang M., Sun J., Liu J., Jia Z., Zhao D. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis. J.Atheroscler. Thromb. 2014, 21:532-542.
29. Ikram M.K., De Jong F.J., Van Dijk E.J., Prins N.D., Hofman A., Breteler M.M., De Jong P.T. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain 2006, 129:182-188.
30. Gregson J., Stirnadel-Farrant H.A., Doobaree I.U., Koro C. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature. Atherosclerosis 2012, 225:11-21.
31. Elkind M.S., Leon V., Moon Y.P., Paik M.C., Sacco R.L. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction. Stroke 2009, 40:3233-3237.
32. Ferguson J.F., Hinkle C.C., Mehta N.N., Bagheri R., Derohannessian S.L., Shah R., Mucksavage M.I., Bradfield J.P., Hakonarson H., Wang X., Master S.R., Rader D.J., Li M., Reilly M.P. Translational studies of lipoprotein-associated phospholipase A[U+2082] in inflammation and atherosclerosis. J.Am. Coll. Cardiol. 2012, 59:764-772.